fluorescein-5-isothiocyanate has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acton, E; Anderson, T; Azcona-Olivera, J; Barth, D; Keeney, M; Kuek, N; Sutherland, DR | 1 |
| Chikayama, S; Ikeda, M; Kimura, S; Kobayashi, Y; Kondo, M; Maruo, N; Ozawa, M; Sugano, T; Takahashi, Y; Tanaka, K; Uoshima, N; Wada, K | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Use of a FLAER-based WBC assay in the primary screening of PNH clones.
Topics: Anemia, Aplastic; Bacterial Toxins; CD59 Antigens; Clone Cells; Erythrocyte Count; Flow Cytometry; Fluorescein-5-isothiocyanate; Hemoglobinuria, Paroxysmal; Humans; Leukocyte Count; Myelodysplastic Syndromes; Pore Forming Cytotoxic Proteins; Sensitivity and Specificity | 2009 |
Comparison of the DNA content of megakaryocytes identified immunologically with that identified morphologically.
Topics: Bone Marrow Examination; Case-Control Studies; DNA; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Indoles; Megakaryocytes; Myelodysplastic Syndromes; Platelet Glycoprotein GPIIb-IIIa Complex; Ploidies | 1997 |